Summary Safety Review - Atypical...
Dataset description:
Health Canada reviewed the potential risk of DRESS with the use of atypical antipsychotics, following the manufacturers’ voluntary update of the product safety information for Zyprexa...
There are no views created for this dataset yet.
Additional Information
| Field | Value |
|---|---|
| Data last updated | October 22, 2024 |
| Metadata last updated | October 22, 2024 |
| Created | October 22, 2024 |
| Format | HTML |
| License | Open Government Licence - Canada |
| Has views | False |
| Id | af446847-8c75-4cda-9222-4063b6d24530 |
| Package id | f5ba4df7-f285-42e8-9519-cedbe71cb5f7 |
| Position | 1 |
| State | active |